4/10/2024

Isosorbide Mononitrate Immediate-Release Tablets

Products Affected - Description

- Isosorbide mononitrate oral immediate release tablet, Teva, 10 mg, bottle, 100 count, NDC 00228-2631-11
- Isosorbide mononitrate oral immediate release tablet, Teva, 20 mg, bottle, 100 count, NDC 00228-2620-11

Reason for the Shortage

- Teva did not provide a reason for the shortage.
- Teva is the sole supplier of isosorbide mononitrate immediate-release tablets.

Available Products

- There are no presentations available

Estimated Resupply Dates

- Teva has isosorbide mononitrate immediate-release tablets on back order and the company estimates a release date of mid- to late-April 2024 for the 10 mg tablets and late-May 2024 for the 20 mg tablets.

Updated

Updated April 10, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created April 5, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.